MC
ELOS

Muhlenkamp & Co’s Syneron Medical Ltd ELOS Stock Holding History

Muhlenkamp & Co’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10,255
Closed -$79K – 65
2015
Q4 		$79K Buy
+10,255
New +$78.2K 0.02% 53

Other funds holding ELOS

SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Muhlenkamp & Co's ELOS Position: Q1 2016 in Review

Muhlenkamp & Co sold out of Syneron Medical Ltd (ELOS) in Q1 2016, closing a stake of 10,255 shares — an estimated $79K sold.

Muhlenkamp & Co first reported a position in ELOS in Q4 2015 and held it in 1 quarter. The position peaked at $79K in Q4 2015. 61 funds tracked by Wall St. Rank hold ELOS as of Q1 2016.

  • Muhlenkamp & Co reported no remaining Syneron Medical Ltd position as of Q1 2016 after selling out during the quarter.
  • Muhlenkamp & Co sold 10,255 Syneron Medical Ltd shares in Q1 2016, an estimated $79K.
  • Muhlenkamp & Co first reported a position in Syneron Medical Ltd in Q4 2015 and held it in 1 quarter.
  • Muhlenkamp & Co's Syneron Medical Ltd position peaked at $79K in Q4 2015.
  • 61 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q1 2016.

Based on Muhlenkamp & Co's 13F filing for Q1 2016, filed 12 May 2016.